Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)

Clinical trial NCT04597671 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04597671
Sponsor: Association NVALT Studies
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2021-12-06
Primary completion: 2028-12-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.